Exogenous Cushing's Syndrome - Symptoms, Causes, Treatment & Prevention

Overview

Exogenous Cushing’s syndrome is a form of hypercortisolism that occurs when the body is exposed to high levels of glucocorticoids from an outside source—most commonly prescribed corticosteroid medications. Unlike endogenous Cushing’s syndrome, where the body produces excess cortisol on its own, exogenous Cushing’s results from prolonged use of drugs such as prednisone, dexamethasone, or hydrocortisone.

The condition can affect anyone who takes glucocorticoids for a long period, but it is most common in adults receiving treatment for chronic inflammatory or autoimmune diseases (e.g., rheumatoid arthritis, asthma, inflammatory bowel disease). Women appear slightly more often affected than men, likely because many autoimmune conditions are more prevalent in females.

Estimates suggest that up to 10%–20% of patients on chronic systemic steroids develop some degree of Cushingoid features, while clinically overt exogenous Cushing’s syndrome is seen in roughly 1%–2% of long‑term users.^{[1] Mayo Clinic} The prevalence rises sharply when daily prednisone equivalents exceed 10 mg for more than 3–6 months.

Symptoms

Symptoms result from the actions of excess cortisol on multiple organ systems. Not every patient will experience all of them; the pattern can vary based on dose, duration, and individual susceptibility.

Typical Cushingoid Features

• Weight gain and central obesity – a “moon‑shaped” face and increased abdominal fat, often with a thin extremities.
• Facial rounding (moon facies) – soft, puffy cheeks.
• Skin changes – fragile skin that bruises easily, purple or pink stretch marks (striae) on the abdomen, thighs, breasts, or arms.
• Muscle weakness – especially proximal muscles (hip and shoulder girdle) leading to difficulty climbing stairs or lifting objects.
• Hypertension – high blood pressure is present in up to 70% of patients.

Metabolic and Endocrine Manifestations

• Hyperglycemia or new‑onset type 2 diabetes.
• Elevated triglycerides and cholesterol (dyslipidemia).
• Osteoporosis and increased fracture risk.
• Gonadal suppression – menstrual irregularities, hirsutism, or decreased libido.

Neuropsychiatric Symptoms

• Mood swings, irritability, anxiety, or depression.
• Difficulty concentrating, memory problems (“brain fog”).
• Rarely, psychosis in high‑dose cases.

Other Possible Signs

• Facial plethora (redness) and flushing.
• Increased susceptibility to infections.
• Delayed wound healing.
• Thin, easily eroded gums and oral ulcers.

Causes and Risk Factors

Exogenous Cushing’s syndrome is iatrogenic—caused by medical therapy. The most common culprits are oral or intravenous glucocorticoids, but topical, inhaled, intra‑articular, and epidural steroids can also contribute when used in high doses or over long periods.

Primary Causes

• Systemic glucocorticoids – prednisone, prednisolone, methylprednisolone, dexamethasone, hydrocortisone.
• Inhaled steroids – high‑dose fluticasone or budesonide, especially when combined with oral steroids.
• Topical steroids – potent preparations applied over large surface areas or under occlusion.
• Intra‑articular or epidural injections – repeated high‑dose injections for joint or back pain.

Risk Factors

• Daily prednisone-equivalent dose >10 mg for >3 months.
• Use of long‑acting steroids (e.g., dexamethasone) without tapering.
• Underlying diseases that require high‑dose steroids (e.g., systemic lupus erythematosus, vasculitis).
• Female sex and older age (≥60 years) – both increase susceptibility to bone loss and metabolic effects.
• Concurrent use of medications that inhibit steroid metabolism (e.g., ketoconazole, ritonavir).

Diagnosis

Diagnosing exogenous Cushing’s syndrome focuses on recognizing the clinical picture and confirming that excess cortisol is due to external sources rather than endogenous overproduction.

Step‑by‑Step Approach

1. Detailed medication history – dose, route, duration, and recent changes in glucocorticoid therapy.
2. Physical examination – looking for classic signs described above.
3. Biochemical testing – to demonstrate suppressed endogenous cortisol production:
   • 24‑hour urinary free cortisol (UFC) – typically low or normal in exogenous disease.
   • Late‑night salivary cortisol – also low.
   • Morning plasma ACTH – suppressed (<5 pg/mL) because feedback inhibition.
4. Imaging (if needed) – usually not required unless endogenous Cushing’s must be ruled out (e.g., MRI of the pituitary). In most cases, a normal adrenal gland on CT supports an exogenous cause.

Key Diagnostic Criteria

• Documented exposure to glucocorticoids at a dose known to cause Cushingoid features.
• Clinical signs consistent with hypercortisolism.
• Suppressed endogenous cortisol production (low ACTH, low UFC).

Guidelines from the Endocrine Society recommend confirming suppression before initiating a taper, as abrupt withdrawal can precipitate adrenal crisis.^{[2] Endocrine Society Clinical Practice Guideline}

Treatment Options

Treatment centers on reducing exogenous glucocorticoid exposure while managing the symptoms caused by prior excess cortisol.

1. Tapering the Steroid

• Gradual dose reduction is essential to allow the hypothalamic‑pituitary‑adrenal (HPA) axis to recover.
• Typical taper schedules start with a 10%‑20% reduction every 1–2 weeks, adjusted based on symptoms and cortisol levels.
• In patients on very high doses or long‑term therapy (>6 months), an “alternate‑day” regimen may be introduced before tapering.

2. Steroid‑Sparing Alternatives

Switching to non‑steroidal agents can control the underlying disease while allowing steroid reduction.

• Biologic therapies for rheumatoid arthritis (e.g., adalimumab, rituximab).
• DMARDs for autoimmune disorders (e.g., methotrexate, azathioprine).
• Inhaled corticosteroid step‑down in asthma (e.g., using the lowest effective dose, adding long‑acting bronchodilators).

3. Medications to Address Metabolic Effects

• Antihypertensives – ACE inhibitors, ARBs, calcium‑channel blockers.
• Antidiabetic agents – metformin, SGLT2 inhibitors, or insulin if needed.
• Bone‑protective drugs – calcium, vitamin D, and bisphosphonates (alendronate, zoledronic acid) or denosumab.
• Lipid‑lowering therapy – statins.

4. Psychological Support

Referral to mental‑health professionals is recommended for depression, anxiety, or severe mood changes. Cognitive‑behavioral therapy and, when indicated, short‑term antidepressants can be helpful.

5. Surgical or Procedural Interventions

These are rare for exogenous disease but may be necessary if the underlying condition requires continued high‑dose steroids (e.g., refractory inflammatory eye disease). In such cases, bilateral adrenalectomy is considered only as a last resort and after multidisciplinary review.

Living with Exogenous Cushing’s Syndrome

Managing daily life focuses on gradual steroid reduction, monitoring for adrenal insufficiency, and mitigating long‑term complications.

Practical Tips

• Maintain a medication log – include dose, timing, and any side‑effects.
• Monitor blood pressure and glucose – home sphygmomanometer and glucometer can help track trends.
• Follow a balanced diet – low‑sodium, high‑protein, calcium‑rich foods; limit simple sugars.
• Regular weight‑bearing exercise – 150 min/week of moderate activity (e.g., walking, resistance bands) to preserve bone and muscle mass.
• Stay hydrated – cortisol can promote sodium retention and potassium loss.
• Carry a “steroid card” or medical alert bracelet indicating current glucocorticoid dose in case of emergency.
• Schedule routine follow‑up labs every 3–6 months (CBC, fasting glucose, lipid panel, bone density).

Adrenal Insufficiency Precautions

During tapering, the body’s own cortisol production may be insufficient, especially under stress (illness, surgery, trauma). Patients should:

• Learn the “sick‑day rule”: double the usual steroid dose during moderate stress (e.g., fever) and use an emergency injection (e.g., 100 mg hydrocortisone IM) for severe stress.
• Keep an emergency hydrocortisone kit and know how to use it.
• Inform family, friends, and healthcare providers about their steroid regimen.

Prevention

While glucocorticoids are sometimes unavoidable, several strategies can reduce the risk of developing exogenous Cushing’s syndrome.

• Prescribe the lowest effective dose and limit duration whenever possible.
• Prefer non‑systemic routes (topical, inhaled, intra‑articular) when clinically appropriate.
• Implement “steroid holidays” or intermittent dosing for chronic conditions under specialist supervision.
• Use steroid‑sparing agents early in disease management.
• Educate patients on side‑effects and the importance of reporting early Cushingoid changes.
• Regularly reassess the need for ongoing steroids at each clinic visit.

Complications

If untreated or if high‑dose steroids continue, a range of serious complications may arise.

• Cardiovascular disease – hypertension, atherosclerosis, and increased risk of myocardial infarction or stroke.
• Diabetes mellitus – chronic hyperglycemia leading to microvascular (retinopathy, nephropathy) and macrovascular complications.
• Osteoporosis and fractures – especially vertebral compression fractures.
• Infections – opportunistic infections (e.g., candidiasis, Pneumocystis jirovecii) due to immunosuppression.
• Psychiatric disorders – severe depression, anxiety, or psychosis.
• Skin thinning and poor wound healing – increasing risk of postoperative complications.
• Adrenal crisis – life‑threatening acute adrenal insufficiency if steroids are stopped abruptly.

When to Seek Emergency Care

Call 911 or go to the nearest emergency department if you experience any of the following while tapering steroids or after a sudden dose change:

• Severe weakness, dizziness, or fainting.
• Sudden, intense abdominal or back pain.
• Vomiting, diarrhea, or inability to keep fluids down.
• Low fever with chills, or signs of infection (e.g., rapid breathing, swollen lymph nodes).
• Confusion, severe headache, or visual disturbances.
• Sudden drop in blood pressure (feeling light‑headed when standing).

These symptoms may indicate adrenal crisis or a serious infection and require immediate treatment with intravenous hydrocortisone and supportive care.

---

References:
[1] Mayo Clinic. Exogenous Cushing syndrome. https://www.mayoclinic.org (accessed May 2026).
[2] Endocrine Society. Clinical Practice Guideline for the Diagnosis and Treatment of Cushing’s Syndrome. https://www.endocrine.org (2023).
Additional data from CDC, NIH, WHO, and Cleveland Clinic.